| Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy A Dayakar, S Chandrasekaran, SV Kuchipudi, SK Kalangi Frontiers in immunology 10, 670, 2019 | 194 | 2019 |
| Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine SK Kalangi, A Dayakar, D Gangappa, R Sathyavathi, RS Maurya, DN Rao Experimental Parasitology 170, 184-192, 2016 | 65 | 2016 |
| Emergence of leptin in infection and immunity: scope and challenges in vaccines formulation D Alti, C Sambamurthy, SK Kalangi Frontiers in cellular and infection microbiology 8, 147, 2018 | 53 | 2018 |
| Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits T Chandramohan Reddy, P Aparoy, N Kishore Babu, K Anil Kumar, ... Protein and Peptide Letters 17 (10), 1251-1257, 2010 | 50 | 2010 |
| Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications M Gokara, T Malavath, SK Kalangi, P Reddana, R Subramanyam Journal of Biomolecular Structure and Dynamics 32 (8), 1290-1302, 2014 | 49 | 2014 |
| Gold–silver bimetallic nanoparticles reduced with herbal leaf extracts induce ROS-mediated death in both promastigote and amastigote stages of Leishmania donovani D Alti, M Veeramohan Rao, DN Rao, R Maurya, SK Kalangi ACS omega 5 (26), 16238-16245, 2020 | 48 | 2020 |
| Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper (II), nickel (II) and palladium (II) complexes M Jagadeesh, M Lavanya, SK Kalangi, Y Sarala, C Ramachandraiah, ... Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 135, 180-184, 2015 | 44 | 2015 |
| Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors P Aparoy, KK Reddy, SK Kalangi, TC Reddy, P Reddanna Bioorganic & medicinal chemistry letters 20 (3), 1013-1018, 2010 | 29 | 2010 |
| Halo-substituted thiosemicarbazones and their copper (II), nickel (II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human … M Jagadeesh, SK Kalangi, LS Krishna, AV Reddy Spectrochimica Acta Part A: molecular and biomolecular spectroscopy 118, 552-556, 2014 | 25 | 2014 |
| Role of Biosynthesized Ag-NPs using Aspergillus niger (MK503444. 1) in Antimicrobial, Anti-cancer and Anti-angiogenic activities SC Pawar, A Pasha, DV Kumbhakar, SS Sana, D Ravinder, BV Lakshmi, ... Frontiers in Pharmacology, 4081, 2022 | 15 | 2022 |
| Tumor microenvironment determines drug efficacy in vitro-apoptotic and anti-inflammatory effects of 15-lipoxygenase metabolite, 13-HpOTrE C Wolff, C Zoschke, SK Kalangi, P Reddanna, M Schäfer-Korting European Journal of Pharmaceutics and Biopharmaceutics 142, 1-7, 2019 | 13 | 2019 |
| Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model PR Suresh K. Kalangi,Nitin K. Swarnakar, R. Sathyavathi, D. Narayana Rao ... Oxidative Medicine and Cellular Longevity, 2018 | 13 | 2018 |
| The role of pi, glutamine and the essential amino acids in modulating the metabolism in diabetes and cancer L Vadlakonda, M Indracanti, SK Kalangi, BM Gayatri, NG Naidu, ... Journal of Diabetes & Metabolic Disorders 19, 1731-1775, 2020 | 8 | 2020 |
| Bioimaging of 5 fluorouracil conjugated to CdTe quantum dots in MCF-7 breast cancer cells SK Kalangi, R Sathyavathi, DN Rao, R Pallu Journal of Bionanoscience 6 (1), 17-22, 2012 | 7 | 2012 |
| Spectrum of microRNAs and their target genes in cancer: Intervention in diagnosis and therapy A Dayakar, KD Shanmukha, SK Kalangi Molecular Biology Reports 49 (7), 6827-6846, 2022 | 6 | 2022 |
| Histone deacetylase (HDACs) inhibitors: Clinical applications KD Shanmukha, H Paluvai, SK Lomada, M Gokara, SK Kalangi Progress in Molecular Biology and Translational Science 198, 119-152, 2023 | 3 | 2023 |
| Endocytosis of LXRs: Signaling in liver and disease M Brahma, S Ghosal, M Maruthi, SK Kalangi Progress in Molecular Biology and Translational Science 194, 347-375, 2023 | 3 | 2023 |
| Introduction to aggregation induced emission (AIE) materials S Bandyopadhyay, SK Kalangi, V Singh, RS Bhosale Progress in Molecular Biology and Translational Science 184, 1-9, 2021 | 3 | 2021 |
| Advances in aggregation induced emission (AIE) materials in biosensing and imaging of bacteria M Maruthi, SK Kalangi Progress in Molecular Biology and Translational Science 184, 61-79, 2021 | 3 | 2021 |
| Trend of regulatory T-Cells in the pathogenesis of Leishmania infection D Alti, SK Kalangi Biomedical Journal of Scientific & Technical Research 10 (5), 8083-8085, 2018 | 3 | 2018 |
Pallu ReddannaEmeritus Professor在 uohyd.ac.in 的电子邮件经过验证
